A recent study published in Engineering delves into the complex mechanisms of drug addiction, highlighting the crucial role of astrocytic G protein-coupled receptors (GPCRs).

The increasing occurrence of chronic and infectious diseases is the main driver of the rising demand for interferon. Furthermore, advancements in interferon production and ongoing research and ...

DelveInsight's Interferons Market Insights report provides the current and forecast market analysis, individual leading ...

The Cuban government has announced the addition of new drugs to the National Basic Medicine List, setting their retail prices ...

Sobi® (STO: SOBI), today announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental Biologics License Application (sBLA) for Gamifant® (emapalumab-Izsg) for use in adult ...

The polycythemia vera market over the next few years is expected to substantially change and experience growth, as it will be dominated by two already approved products, Incyte/Novartis' JAKAFI ...

BESREMi is a preferred, FDA-approved option for both symptomatic low- and high-risk polycythemia vera patients. In the polycythemia vera space, BESRE ...

Anifrolumab Is a monoclonal antibody that works by blocking the receptors for type 1 interferon, a biochemical that plays a key role in promoting inflammation, researchers said. It’s given once a ...

Anifolumab Is a monoclonal antibody that works by blocking the receptors for type 1 interferon, a biochemical that plays a key role in promoting inflammation, researchers said. It’s given once a month ...

The interferon (IFN) family of proteins plays key roles in the immune response against viruses and other pathogens. In the context of COVID-19, IFNs have been shown to be key for restraining ...

Get Instant Summarized Text (Gist) SMYD3 acts as a negative regulator of type I interferon signaling by catalyzing the dimethylation of IRF3 at lysine 39. This modification inhibits IRF3's ...